Found 1,117 investors
Thomas Albert
United States
Mr. Frank Leo serves as a Board of Director at Ocugen. Frank is a 30-year veteran of the pharmaceutical and healthcare industries having experience with publicly-traded, private equity-backed, and start-up companies in the capacity of executive, investor, and advisor. From 1999 to 2004, Mr. Leo served as President and Group President of Sterile Technologies and Life Sciences at Cardinal Health. He joined Cardinal Health following its acquisition of the sterile pharmaceutical contract manufacturing company Automatic Liquid Packing (ALP), where he held various senior level positions including Chief Operating Officer during his 16-year career. At Cardinal Health he oversaw the growth of the biotechnology and life sciences group, which was later spun out to form Catalent Inc. Mr. Leo left Cardinal Health in 2004 but continued to serve as a retained advisor through 2005. Mr. Leo joined Morton Grove Pharmaceuticals where he served as CEO from 2006 to 2007, overseeing its sale for its private equity owners in 2007. Mr. Leo served as a Board Member of Rx Elite, Monogen, GeneraMedix, and Capsugel. Mr. Leo is a serial entrepreneur, having been involved in business value creation and start-ups in the sterile drug, biotechnology and healthcare technology spaces.
Individual/Angel
Thomas Benita
United States
Mr. Jiang Lin serves as Principal at F-Prime Capital. He serves as Board Member at Hone (Education and Training Services). He serves as a Partner at Swift Ventures. He served as Board Member at Mathison. He served as Principal at Trinity Ventures. He is an Angel Investor. He served as an Associate at Globespan Capital Partners. John Lin supports deal sourcing, evaluation of investment opportunities, and due diligence, as well as helps entrepreneurs with strategy and operations. Prior to Globespan, John was a Business Analyst at McKinsey & Company, where he helped clients in technology, retail, healthcare, and finance on a variety of issues, including strategy, marketing and sales, IT, and operations. In addition, John also worked in Business Development at Yelp and as an Associate at ZS Associates. John graduated with honors from UC Berkeley with degrees in Computer Science and Business. While at Berkeley, he consulted for a number of non-profits; including Goodwill and the Bay Area Biotech Education Consortium.
Individual/Angel
Thomas Kunz
United Kingdom
Mr. Ahmad Mortazavi serves as Chief Executive Officer & Board Member at e-Therapeutics. He has been appointed Executive Chairman with effect from 11th February 2020. Mr Mortazavi has extensive experience in the biotechnology sector and financial markets. Recent roles include CEO of Silence Therapeutics plc from 2012-2018 as well as a founder shareholder of Evolution Group, a U.K. based Investment Bank, from 2001-2008. Ali is an experienced investor in small companies and has held numerous declarable stakes in listed and private biotechnology and technology companies. Current directorships: Hannesami LLP. Previous directorships held in the last 5 years: Silence therapeutics PLC He served as Co-Chairman at Ultromics.
Individual/Angel
Thynk Capital
United States
Founded in 2003, Thynk Capital is a venture capital investment firm that prefers to invest in therapeutics, healthcare and technology companies. The firm focuses on early stage pharma and biotech developing treatment to Extend Healthy lifespan and address the major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Diabetes, Frailty and Rare Disease.
Venture Capital
Timezone Ventures
United Kingdom
Timezone Ventures is a venture capital investment firm which prefers to make early-stage investments in the fin-tech, internet of things, artificial intelligence, e-commerce, biotechnology and consumer goods sectors. The firm is headquartered in London, United Kingdom.
Venture Capital
Timothy Howes
United States
Alan Auerbach serves as Chief Executive Officer, President and Chairman at Puma Biotechnology. Prior to founding Puma, Mr. Auerbach Founded Cougar Biotechnology and served as its Chief Executive Officer, President and a Board Member. From July 2009 until January 2010, Mr. Auerbach served as Co-Chairman of the Integration Steering Committee at Cougar (as part of Johnson & Johnson) that provided leadership and oversight for the development and global commercialization of Cougar's lead product candidate, abiraterone acetate. Abiraterone was approved for the treatment of metastatic prostate cancer in the U.S. in April 2011 and in the European Union in September 2011. Prior to founding Cougar, from June 1998 to April 2003 Mr. Auerbach was Vice President, Senior Research Analyst at Wells Fargo Securities, where he was responsible for research coverage of small- and middle- capitalization biotechnology companies, with a focus on companies in the field of oncology. He had primary responsibility for technical, scientific and clinical due diligence, as well as selection of biotechnology companies followed by the company. During 2002, Mr. Auerbach ranked second in the NASDAQ/Starmine survey of analyst performance for stock picking in biotechnology. From August 1997 to May 1998, Mr. Auerbach was a Vice President, Research Analyst at the Seidler Companies, Inc., where he was responsible for research coverage of small-capitalization biotechnology companies. Prior to his work as a biotechnology analyst, Mr. Auerbach worked for Diagnostic Products Corporation, where he designed and implemented clinical trials in the field of oncology. Mr. Auerbach currently serves as a director of Radius Health, a pharmaceutical company focused on developing new drugs for osteoporosis and women's health. Mr. Auerbach received a B.S. in Biomedical Engineering from Boston University and an M.S. in Biomedical Engineering from the University of Southern California. He is also an Angel Investor.
Individual/Angel
T-Investment (VC)
South Korea
T Investment is a venture capital firm based in Seoul, South Korea. The firm seeks to invest in artificial intelligence/ robotics, fintech, 5G, biotech, and digital healthcare sector.
Venture Capital
Tivona Capital
Canada
Tivona Capital is a private equity investment firm that is headquartered in Toronto, Canada and was founded in 1997. The firm prefers to invest in the real estate, technology and biotechnology sectors. It provides its investments with financing, management expertise and access to a broad professional network.
Private Equity Firm
TMC Innovation
United States
Founded in 2015, TMC Innovation is an accelerator program based in Houston, Texas. The firm seeks to provide acceleration services for healthcare startups. The firm prefers to invest in the digital health and life sciences, entrepreneurship, health tech, medical devices and diagnostics and biotechnology sectors.
Accelerator
Incubator
TOGO Ventures
United States
Axial is a venture capital firm. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in the biotechnology and life sciences sectors.
Venture Capital
Tollman Capital Partners
Japan
Founded in 2000, Biotech Healthcare Partners is a venture capital firm specializing in the biotechnology and healthcare sector investment in the Asia Pacific region. The firm is based in Tokyo, Jpan.
Venture Capital
Top Taiwan Venture Capital Group
Taiwan
Founded in 1996, Top Taiwan Venture Capital Group is a venture capital management firm based in Taipei City, Taiwan. The firm seeks to invest in industries such as technology, biotechnology, renewable energy, consumer retail, food & beverages, healthcare and auto parts.
Venture Capital
Tore Schiotz
Oslo, Oslo, Norway
Serving as Managing Partner in Contango Kapital, a management company for the investment fund Energy Future Invest, where he also serves as ...
Investment Partner
Toshi Otani
Palo Alto, California, United States
Toshi invests in cloud, mobile, infrastructure, and IoT companies with an enterprise focus. He also leads TransLink’s activities supporting ...
Investment Partner
Individual/Angel
Total Medical Ventures
United Kingdom
Total Medical Ventures is a venture capital firm which seeks to invest in the life sciences, diagnostics, healthcare, drug development and biotechnology sectors. The firm is based in Cambridge, United Kingdom.
Venture Capital
TPG Biotech
San Francisco, California, United States
TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.
Biotechnology
Finance
Venture Capital
Private Equity Firm
Venture Capital
Treehouse Global Ventures
United States
Founded in 2018, Treehouse Global Ventures is an investment fund based in Newtown Square, Pennsylvania. The firm specializes in venture capital investments. The firm prefers to invest in consumer products and services, data, Software & artificial intelligence, medical and biotechnology, cultivation & agriculture, testing, consumer & retail, education, regulation & compliance, logistics, brand marketing, manufacturing & distribution and healthcare sectors.
Venture Capital
T-REGS
United States
Founded in 2012, Alignment Ventures is a venture capital firm based in Reno, Nevada. The firm seeks to invest in the biotech, medical device, health care IT, and life sciences sectors.
Venture Capital
Triatomic Capital
United States
Triatomic Capital is a venture capital firm based in Nevada. The firm seeks to invest in healthtech, deeptech, biotechnology, medtech, energy and artificial intelligence sectors.
Venture Capital
Trident Partners
China
Mr. Jie Yin serves as Managing Partner & President at Kaitai Capital. Jie is responsible for the investment and management of biotechnology, health and community innovation and consumption upgrading, focusing on the fields of biomedicine, bio-agriculture, medical service and health, super factory and community innovation. Jie graduated from Zhejiang University with a master's degree in economics.
Individual/Angel
Showing 1021 to
1040 of
1,117 results